CatalystPit

NVONOVO NORDISK A S

NYSE · Pharmaceutical Preparations
Last close $37.91 · 2026-09-30
ABOUT
ExchangeNYSE
SectorHealthcare
IndustryPharmaceutical Preparations
INSTITUTIONAL OWNERSHIP
Institutional holders1,503
Shares held347,503,057
Value$17.43B
As of quarter end2026-06-30
RECENT CONGRESSIONAL TRADES
  • 2026-03-30 · Alan Armstrong · BUY · $15,001 - $50,000
  • 2025-10-15 · Hon. Marjorie Taylor Greene · BUY · $1,001 - $15,000
  • 2025-08-28 · Hon. Marjorie Taylor Greene · BUY · $1,001 - $15,000
  • 2025-08-19 · Hon. Marjorie Taylor Greene · BUY · $15,001 - $50,000
  • 2025-08-04 · Hon. Scott Scott Franklin · BUY · $15,001 - $50,000
RECENT NEWS
  • Novo Nordisk’s CEO Was Asked Why His Stock Keeps Falling on Good News
  • Novo Nordisk Vs. Eli Lilly: Judged Against Big Pharma, Only One Needs A Premium
  • Novo Nordisk initiates share repurchase programme worth DKK 15 billion
  • FDA extends review for Novo Nordisk's denecimig for hemophilia A
  • Novo Nordisk: The Street Sold It For The Wrong Reason
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
NOVO NORDISK A S (NVO) · Stock Price, Congress Trades, Institutional Holdings · CatalystPit